$ACHC

Acadia Healthcare Company, Inc.

CIK:0001520697|SEC Filings

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 865,839	$ 869,232	$ 1,694,641	$ 1,639,737
Salaries, wages and benefits (including equity-based compensation expense of $10,990, $10,549, $18,946 and $19,226, respectively)	474,095	452,417	941,135	897,688
Professional fees	55,760	49,961	108,957	95,668
Supplies	30,197	28,532	59,688	56,874
Rents and leases	11,844	12,610	23,577	24,266
Other operating expenses	155,747	134,414	286,826	248,416
Depreciation and amortization	50,427	48,995	102,853	96,027
Interest expense, net	38,178	35,138	76,508	64,320
Debt extinguishment costs				1,269
Legal settlements expense			13,751	3,504
Loss on impairment	7,364	1,452	7,364	1,452
Gain on sale of property, net	(2,359)	(8,715)	(3,581)	(8,715)
Transaction, legal and other costs	22,579	64,425	44,592	95,497
Total expenses	843,832	819,229	1,661,670	1,576,266
Income before income taxes	22,007	50,003	32,971	63,471
Provision for income taxes	9,747	12,067	16,247	16,471
Net income	12,260	37,936	16,724	47,000
Net income attributable to noncontrolling interests	(1,332)	(7,809)	(1,691)	(8,499)
Net income attributable to Acadia Healthcare Company, Inc.	$ 10,928	$ 30,127	$ 15,033	$ 38,501
Earnings per share attributable to Acadia Healthcare Company, Inc. stockholders:
Basic	$ 0.12	$ 0.33	$ 0.17	$ 0.42
Diluted	$ 0.12	$ 0.33	$ 0.16	$ 0.42
Weighted-average shares outstanding:
Basic	90,817	90,328	90,675	90,987
Diluted	91,374	90,435	91,205	91,400

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities:
Net income	$ 16,724	$ 47,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	102,853	96,027
Amortization of debt issuance costs	2,517	2,278
Equity-based compensation expense	18,946	19,226
Deferred income taxes	20,604	(8,753)
Debt extinguishment costs		1,269
Non-cash legal settlements expense		3,504
Loss on impairment	7,364	1,452
Gain on sale of property, net	(3,581)	(8,715)
Other	516	1,128
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(30,146)	(42,660)
Other current assets	30,356	(3,797)
Other assets	(572)	(7,684)
Accounts payable and other accrued liabilities	36,195	27,684
Accrued salaries and benefits	(16,631)	(3,940)
Other liabilities	38,453	20,962
Net cash provided by operating activities	223,598	144,981
Investing activities:
Cash paid for acquisitions, net of cash acquired		(8,165)
Cash paid for capital expenditures	(115,117)	(342,378)
Proceeds from sale of property and equipment	26,497	16,623
Other	(4,270)	(101)
Net cash used in investing activities	(92,890)	(334,021)
Financing activities:
Borrowings on long-term debt		1,200,000
Principal payments on revolving credit facility	(160,000)	(1,035,000)
Principal payments on long-term debt	(12,188)	(4,063)
Repayment of long-term debt		(670,856)
Payment of debt issuance costs		(18,615)
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises	(3,807)	(3,716)
Repurchase of common stock		(50,034)
Contributions from noncontrolling partners in joint ventures	990
Distributions to noncontrolling partners in joint ventures	(2,593)	(1,990)
Cash paid for contingent consideration		(1,500)
Other	(62)	(70)
Net cash (used in) provided by financing activities	(92,660)	244,156
Net increase in cash and cash equivalents	38,048	55,116
Cash and cash equivalents at beginning of the period	133,242	76,305
Cash and cash equivalents at end of the period	171,290	131,421
Effect of acquisitions:
Assets acquired, excluding cash	20,760	19,881
Liabilities assumed		(842)
Redeemable noncontrolling interest resulting from an acquisition	(20,760)	(10,874)
Cash paid for acquisitions, net of cash acquired		8,165
New Credit Facility [Member]
Financing activities:
Borrowings on revolving credit facility	$ 85,000	$ 830,000

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 171,290	$ 133,242
Accounts receivable, net	470,750	440,604
Other current assets	203,247	240,293
Total current assets	845,287	814,139
Property and equipment, net	3,089,801	3,111,212
Goodwill	1,303,272	1,296,342
Intangible assets, net	100,186	96,672
Deferred tax assets	2,457	2,528
Operating lease right-of-use assets	138,923	134,005
Other assets	66,399	72,550
Total assets	5,546,325	5,527,448
Current liabilities:
Current portion of long-term debt	32,500	28,438
Accounts payable	135,258	150,403
Accrued salaries and benefits	177,525	188,638
Current portion of operating lease liabilities	20,755	21,160
Other accrued liabilities	171,541	136,555
Total current liabilities	537,579	525,194
Long-term debt	2,382,069	2,471,529
Deferred tax liabilities	87,137	66,605
Operating lease liabilities	128,851	121,961
Other liabilities	218,842	201,607
Total liabilities	3,354,478	3,386,896
Redeemable noncontrolling interests	212,725	191,592
Equity:
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued
Common stock, $0.01 par value; 180,000,000 shares authorized; 90,868,250 and 90,452,483 issued and outstanding at June 30, 2026 and December 31, 2025, respectively	909	905
Additional paid-in capital	2,729,021	2,713,896
Accumulated deficit	(750,808)	(765,841)
Total equity	1,979,122	1,948,960
Total liabilities and equity	$ 5,546,325	$ 5,527,448